BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30071705)

  • 1. Determinants of Potentially Unnecessary Cervical Cancer Screenings in American Women.
    Seo M; Langabeer II JR
    J Prev Med Public Health; 2018 Jul; 51(4):181-187. PubMed ID: 30071705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening in the US-Mexico border region: a binational analysis.
    Herrera DG; Schiefelbein EL; Smith R; Rojas R; Mirchandani GG; McDonald JA
    Matern Child Health J; 2012 Dec; 16 Suppl 2(0 2):298-306. PubMed ID: 22965734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical and Breast Cancer Screening Among Mexican Migrant Women, 2013.
    Guerrero N; Zhang X; Rangel G; Gonzalez-Fagoaga JE; Martinez-Donate A
    Prev Chronic Dis; 2016 Aug; 13():E104. PubMed ID: 27513995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic factors associated with overuse of Pap testing.
    Kepka D; Breen N; King JB; Meissner HI; Roland KB; Benard VB; Saraiya M
    Am J Prev Med; 2014 Nov; 47(5):629-33. PubMed ID: 25175763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
    Qin J; Saraiya M; Martinez G; Sawaya GF
    JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of State Cervical Cancer Insurance Mandates on Pap Test Rates.
    Bitler MP; Carpenter CS
    Health Serv Res; 2017 Feb; 52(1):156-175. PubMed ID: 26989837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Health Care Providers and Patients in Initiation of Unnecessary Papanicolaou Testing After Total Hysterectomy.
    Guo F; Kuo YF
    Am J Public Health; 2016 Nov; 106(11):2005-2011. PubMed ID: 27631753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in the United States, 1993-2010: characteristics of women who are never screened.
    Chen HY; Kessler CL; Mori N; Chauhan SP
    J Womens Health (Larchmt); 2012 Nov; 21(11):1132-8. PubMed ID: 22873781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic disparities in cervical and breast cancer screenings by nativity and length of U.S. residence.
    La Frinere-Sandoval QNNB; Cubbin C; DiNitto DM
    Ethn Health; 2023 Aug; 28(6):895-911. PubMed ID: 36774194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual- and county-level predictors of cervical cancer screening: a multi-level analysis.
    Akinlotan MA; Weston C; Bolin JN
    Public Health; 2018 Jul; 160():116-124. PubMed ID: 29803186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do age-based discontinuation recommendations influence cervical cancer screening rates? Evidence from the United States' Behavioral Risk Factor Surveillance System, 2016 and 2018.
    Estenson L; Kim N; Jacobson M
    Prev Med; 2023 Jul; 172():107543. PubMed ID: 37182584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical Cancer Screening Among Adult Women in China, 2010.
    Wang B; He M; Chao A; Engelgau MM; Saraiya M; Wang L; Wang L
    Oncologist; 2015 Jun; 20(6):627-34. PubMed ID: 25956407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Cervical Cancer Screening Uptake in Kurdish Women Living in Western Iran, 2014.
    Aminisani N; Fattahpour R; Abedi L; Shamshirgaran SM
    Asian Pac J Cancer Prev; 2016; 17(8):3763-7. PubMed ID: 27644614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
    Katz SJ; Hofer TP
    JAMA; 1994 Aug; 272(7):530-4. PubMed ID: 8046807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with cervical cancer screening in Puerto Rico.
    Ortiz AP; Hebl S; Serrano R; Fernandez ME; Suárez E; Tortolero-Luna G
    Prev Chronic Dis; 2010 May; 7(3):A58. PubMed ID: 20394697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.